Mitometh
Mitometh is a methylated derivative of Mitotane, developed as a potential therapeutic agent for adrenal cancer due to its adrenal-suppressing activity. It has been investigated in both in vitro and in vivo preclinical studies for targeting adrenocortical carcinoma.
Product Specifications
CAS Number
107465-03-2
Smiles
ClC1=CC=C (C=C1) C (C=2C=CC=CC2Cl) C (Cl) (Cl) C
Molecular Formula
C15H12Cl4
Molecular Weight
334.07
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
